Quote:Could you explain this? What I see in holland is that the insurance companies are doing just fine. (we also have a system were you are obliged to take an insurance and where companies cannot refuse to give you an insurance.It may or may not work, since the reformed Dutch system is only 4 years old.
An Experiment with Regulated Competition and Individual Mandates for Universal Health Care: The New Dutch Health Insurance System<blockquote>"The first lesson for the United States is that the new (post-2006) Dutch health insurance model may not control costs. To date, consumer premiums are increasing, and insurance companies report large losses on the basic policies. Second, regulated competition is unlikely to make voters/citizens happy; public satisfaction is not high, and perceived quality is down. Third, consumers may not behave as economic models predict, remaining responsive to price incentives. If regulated competition with "individual mandate's" performs poorly in auspicious circumstances such as the Netherlands, how will this model fare in the United States, where access, quality, and cost challenges are even greater? Might the assumptions of economic theory not apply in the health sector?"</blockquote>
I'd still like to review the profitability, and growth projections for Achmea, CZ, VGZ, Menzis, Agis, and ASR.